Formerly PerkinElmer: PerkinElmer was formed by the merger of the business units of two Standard & Poor's 500 companies, EG&G Inc. (formerly NYSE: EGG, located in Wellesley, Massachusetts) and Perkin-Elmer (formerly NYSE: PKN, located in Norwalk, Connecticut). On May 28, 1999, non-government parties of EG&G Inc. acquired one of Perkin-Elmer's legacy business units (Analytical Instruments) for $425 million and formed the new PerkinElmer Corporation under the name Perkin-Elmer. The company hired new senior management and a new board of directors. At the time, EG&G manufactured a variety of industrial products (including automotive, pharmaceuticals, aerospace equipment, and photographic equipment.) Perkin-Elmer's original board of directors and senior management remained with the reorganized company, which was renamed PE Inc. Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB) were involved in one of the most influential biotech events of that decade, the fierce competition with the Human Genome Project Association, which led to what would later become the Genome Bubble, which was part of the technology bubble.
EG&G was founded in 1931; it was founded in a Boston garage by Harold Edgerton, a professor at the Massachusetts Institute of Technology (MIT), and Kenneth Germeshausen and Herbert Grier, students at MIT, and in 1946, Harold Edgerton, a co-founder of EG&G, was honored by the U.S. Army. In 1946, EG&G co-founder Harold Edgerton was awarded the Medal of Freedom by the U.S. Department of War for his improved flash technology that allowed for nighttime aerial photography. Over the next 30 years, EG&G led the way in the development of optoelectronics with more than 50 exclusive patents. The company was incorporated as a joint stock company in 1947 and officially named EG&G.
1937-1991: The Founding Years
Perkin-Elmer was founded as a partnership between Richard Perkin and Charles Elmer in 1937. Founded in 1937 as a partnership between Richard Perkin and Charles Elmer as an optical design and consulting firm, Perkin-Elmer became involved in the field of analytical instrumentation in 1944, and in the early 1990's became a pioneer in the manufacture of Polymerase Chain Reaction (PCR) equipment, in partnership with the Cetus Corporation (later Hoffmann-La Roche). (later Hoffmann-La Roche) and became pioneers in the polymerase chain reaction (PCR) equipment manufacturing industry. In the 1980s, a joint venture between PerkinElmer and MDS Sciex produced the first commercially available inductively coupled plasma mass spectrometer. In the late 2000s, PerkinElmer partnered with GE Medical Systems as its exclusive supplier of X-ray detectors for advanced medical imaging, in an effort to establish digital as the standard of care.
PerkinElmer also operated an analytical instrumentation business in Germany from 1954 until 2001, when a branch office was established in Bodenseewerk, Burlingame, under the name Bodenseewerk Perkin-Elmer GmbH.
Perkin-Elmer was commissioned to manufacture optical components for the Hubble Space Telescope. Perkin-Elmer was commissioned to manufacture optical components for the Hubble Space Telescope. Fabrication of the primary mirror began in 1979 and was completed in 1981. However, a serious dispute arose with NASA because the polishing went over budget and was not completed as planned. The primary mirror was found to have significant spherical aberration after reaching orbit on STS-31 because the zero-aberration corrector was not properly calibrated. A NASA investigation report severely criticized Perkin-Elmer, accusing it of mismanagement, disregard for written quality guidelines, and disregard for the test data, which pointed to a problem with the calibration.[3] The calibrated optic was found to have a zero-aberration mirror. [3] The calibrated optics were installed in the telescope during the first Hubble Telescope Maintenance and Restoration mission, STS-61. The calibration device, COSTAR, was fully applied to the secondary mirror and the existing instrument was replaced, so that the primary mirror still had a significant aberration.
1992 - 2008: A period of gradual expansion
In 1992, the company merged with Applied Biosystems, and in 1997 it merged again with PerSeptive Biosystems. This merger brought PerkinElmer instruments for mass spectrometry, peptide synthesis, and oligonucleotide synthesis. 1998, PerkinElmer acquired Lumen Technologies, adding short-arc xenon lamps, mercury-xenon lamps, flashlamps, metal-halide lamps, mercury capillaries, electroformed xenon quartz reflectors, and aerospace illuminators to its product portfolio. On July 14, 1999, PerkinElmer, a new analytical instrument manufacturer, eliminated 350 jobs and reduced operating costs by 12% as a result of the reorganization. [2]
In 2000, PerkinElmer acquired NEN Life Science Products, adding to its product line a range of world-class radioactive reagents and instrumentation for genomics, proteomics, and new drug discovery, and in 2001, with the acquisition of Packard BioScience, PerkinElmer expanded its portfolio of analytical instruments for genomics, proteomics, and new drug discovery. With the acquisition of Packard BioScience in 2001, PerkinElmer expanded its business in automation, liquid handling and sample preparation. That same year, PerkinElmer also acquired Analytical Automation Specialists Inc., a leading provider of laboratory information management systems (LIMS), giving PerkinElmer the ability to provide valuable information tools to help customers improve laboratory productivity. In 2005, PerkinElmer expanded its existing photonics business with the acquisition of Elcos AG, adding leading light-emitting diode (LED) solutions.
In 2006, PerkinElmer sold its Fluid Science division for approximately $400 million to shift its strategic focus to the fast-growing health sciences and photonics markets. Following this sale, PerkinElmer acquired a number of leading/fast-growing small businesses, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell and Avalon Instruments. Evotec Technologies, has strengthened PerkinElmer's presence in high-throughput and advanced cellular screening. However, the "Evotec-Technologies" brand remained an asset of Evotec (the former company) until late 2007, when PerkinElmer acquired a license to use it. The acquisition of Avalon Instruments expands PerkinElmer's line of molecular spectrometers.
In late 2006, PerkinElmer acquired Euroscreen Products, which gave PerkinElmer the unique and innovative AequeoScreenTM light-emitting platform for screening a large class of drug targets - G protein-coupled receptors (GPCRs).
PerkinElmer has also continued to expand its medical focus through the acquisition of clinical laboratories and services, including NTD Labs, Pediatrix, Signature Genomics, Surendra, New Wave Biologics and Visen Medical.
In July 2006, PerkinElmer acquired NTD Labs on Long Island, New York, which specialized in prenatal screening research in early pregnancy.
In October 2007, PerkinElmer purchased ViaCell, Inc. with its Boston office and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord.
In 2007, PerkinElmer launched EcoAnalytix(R), a revolutionary problem-solving program designed to solve the world's most pressing problems in food and consumer product safety, water quality, and sustainable energy development, ultimately creating a healthy and safe environment. The program offers a complete suite of solutions for water quality, food quality and biofuels development, including instrumentation, applied method development, product and application support, training and industry knowledge*** sharing.
PerkinElmer also continues to expand its product and service offerings through acquisitions, and in 2007, the company acquired LabMetrix Technologies and Improvision Ltd. a leading provider of cellular imaging software and integrated hardware solutions for life sciences research, headquartered in the United Kingdom.
In March 2008, PerkinElmer acquired Pediatrix Screening Laboratories (formerly Neo Gen Screening) in Bridgeville, Pennsylvania, which specializes in the screening of newborns for a variety of inborn metabolic defects such as phenylketonuria, hypothyroidism and sickle cell disease. The lab has since changed its name to Perkin. The lab has since changed its name to PerkinElmer Genetics, Inc.
2008 - 2010: A Period of Strategic Realignment
In the fourth quarter of 2008, PerkinElmer strategically realigned its business to further shift the company's business to improve human health and environmental safety. This realignment reflects PerkinElmer's strategic mission to proactively create outcomes that help improve human health and environmental safety. To reflect the company's new strategic focus on human health and environmental safety, PerkinElmer, Inc. has changed its slogan from "Precision" to "For a Better Life".
PerkinElmer further strengthened its position with the acquisitions of Arnel Inc. in 2008 and 2009, a recognized leader in custom-designed solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets, and Analytica of Branford, a pioneer and leader in mass spectrometry (MS) and ion source technology. PerkinElmer further strengthens its analytical capabilities.
In September 2009, PerkinElmer acquired the genetic screening business of Surendra Genetic Laboratories (Pvt Ltd.), a leading laboratory in India dedicated to fetal, maternal and newborn health, and Xinbo, a leading diagnostics company in China, advancing its regional and global expansion of diagnostic products.
In February 2010, PerkinElmer further expanded its diagnostics business by establishing the PerkinElmer Health Screening Laboratory in Chennai, India. The laboratory uses advanced technologies to diagnose common and serious health problems in Indian mothers and babies, including: prenatal testing for Down syndrome and other inherited metabolic disorders; testing of pregnant women for pre-eclampsia, diabetes, thyroid disorders and infectious diseases; and testing of newborns for potentially fatal genetic and metabolic disorders. In addition to setting up the laboratory, the company also announced a partnership with MediScan Systems, led by Dr. S. Suresh, the company's founder and India's leading expert in fetal medicine and ultrasound.MediScan is accredited by the UK's Fetal Medicine Foundation President, Dr. Kypros Nicolaides, and is the first official Fetal Medicine Foundation in India. MediScan is accredited by Dr. Kypros Nicolaides, Chairman of the Fetal Medicine Foundation, UK and is the first official Fetal Medicine Foundation Training Center in India.
In April 2010, PerkinElmer acquired Signature Genomic Laboratories, LLC (Signature), founded in 2003 by Lisa G. Shaffer, PhD, and Bassem A. Bejjani, MD, PhD, which focuses on the treatment of patients with unknown physical disabilities and developmental disabilities. Founded in 2003 by Dr. Lisa G. Shaffer and Dr. Bassem A. Bejjani, M.D., Signature focuses on diagnostic cytogenetic testing for chromosomal abnormalities in patients with unspecified physical disabilities and developmental disorders. Signature recently launched a suite of diagnostic services for patients with leukemia.
In August 2010, PerkinElmer acquired VisEn Medical, Inc. This acquisition expanded the company's cellular imaging business, expanding the company's technology and capabilities downstream into the area of latency studies performed by academic research institutions and pharmaceutical companies.
Also in August 2010, PerkinElmer announced the sale of its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III, L.P. for approximately $500 million in cash, for which a definitive agreement has been signed by both parties. IDS, with approximately 3,000 employees and 14 manufacturing facilities worldwide, is a custom-designed, specialty lighting and sensor component, sub-sensor and component supplier. With approximately 3,000 employees and 14 manufacturing facilities worldwide, IDS is a leading global provider of custom-designed specialty lighting and sensor components, subsystems, and integrated solutions to major OEMs providing applications in the health, environmental, and safety sectors.
The business is expected to generate revenues of $300 million in 2010. The divestiture of the IDS business reduces the complexity of the Company's operations, and the Company will be able to re-invest the capital generated from the sale into more attractive human health and environmental safety end markets. human health and environmental safety end markets. Customer Commitment: PerkinElmer acts in the best interest of our customers in everything we do, ensuring that our customers' needs and expectations are understood and that we prioritize solutions to their unique challenges.
Everyone at PerkinElmer is responsible for solving problems that arise during the implementation of our customer-focused strategy, taking a long-term view of each project, and building long-term, productive customer relationships.
Focus on results: Focusing on results is at the forefront of PerkinElmer's philosophy. It is this philosophy that enables PerkinElmer to continue to make important breakthroughs and to fulfill its commitments both inside and outside the organization.
PerkinElmer often sets ambitious but realistic goals, communicates clear and prioritized project plans, and clearly delineates each individual's role in each task.
Ethics and Integrity: Strong thinking and high ethical standards allow for not only wise and prudent decision making, but also the ability to maintain integrity and trust at all times. This is the foundation of PerkinElmer's business operations and the root of PerkinElmer's success at all levels. Every employee at PerkinElmer has a responsibility to consider the ethical implications of every decision and action, and the company encourages its employees to challenge stereotypes, propose innovative solutions, seek out different perspectives, and treat each other with respect.
Action-Oriented: PerkinElmer's expertise and proactive atmosphere create a powerful combination that sets it apart from the competition, and PerkinElmer often anticipates potential opportunities and challenges, responding quickly to complex or uncertain situations.
Teamwork: PerkinElmer develops solutions that are the result of the company's collective wisdom, and has long held the belief that the best results come from a blend of perspectives, wisdom, and experience. PerkinElmer's system of teamwork not only motivates employees to do their best, it provides the support necessary to achieve success, and it fosters communication to ****celebrate achievement.
Working atmosphere: PerkinElmer recruits lifelong learners to grow as they tackle new challenges and provides the tools, encouragement, and support necessary to help them excel.
PerkinElmer employees are always looking to innovate because the opportunities are endless. They are motivated, open-minded, risk-taking, and demonstrate extraordinary talent in achieving their goals. PerkinElmer is committed to conducting business with its customers, shareholders and employees in accordance with the highest standards of ethics and integrity and in compliance with the law.
Corporate Governance: Sound corporate governance is another key element of PerkinElmer's guiding business philosophy. In overseeing the management of the Company's business and protecting the economic interests of our shareholders, PerkinElmer's Board of Directors follows the procedures and principles set forth in this Corporate Governance Guideline. In carrying out this responsibility, the Board of Directors establishes and maintains standards for the Company's employees, officers and directors.
Legal Compliance: PerkinElmer's Compliance Review Committee is responsible for overseeing compliance with laws, regulations, and internal policies governing operations within the Company. To fulfill this role, the committee (comprised of senior PerkinElmer employees) regularly receives reports from a variety of employee representatives from the departments whose compliance we focus on, including Health & Safety, Human Resources, Insurance/Risk Management, and FDA/Quality, among others. This has helped PerkinElmer to implement compliance programs, create additional training opportunities, implement budget requests and take other risk mitigation measures to ensure that programs are well communicated and that business practices are legal and ethical.
Code of Business Conduct: As part of PerkinElmer's commitment, PerkinElmer provides business conduct training and distributes the Code of Business Conduct document to all employees in the expectation that they will not only be aware of the law, but also comply with it.
Environmental Health and Safety (EHS) Commitment: PerkinElmer is committed to protecting the health and safety of our employees, our customers, our communities and our environment. To achieve this goal, we maintain safe and healthy operating environments at all of our business locations, and PerkinElmer is committed to the development of products and services that support human and environmental health programs.PerkinElmer strives to minimize the environmental impact of its manufacturing and operations, advocating the integration of education and programs, processes, and practices that reduce resource consumption and impact on the global climate. climate through education and the integration of programs, processes and practices.
Overview of PerkinElmer's EHS Program: PerkinElmer maintains an integrated and systematic approach to managing and operating its business in a manner that protects the environment, its employees, and the public. PerkinElmer is committed to reducing the overall impact of its operations on the environment through the sharing of best practices across business units, performance monitoring, auditing, and regular management. and conducting audits and periodic management reviews.
Many PerkinElmer workplaces are certified to the International Organization for Standardization (ISO) 14001 standard and the Occupational Health and Safety Management System (OHSAS) 18000 standard.
Product Stewardship: PerkinElmer views product stewardship as a responsibility and an opportunity to solve problems in new ways. PerkinElmer is committed to delivering socially beneficial products and services while minimizing any negative impacts on human and environmental health. PerkinElmer's innovative products provide solutions to major global issues and are designed to make a lasting and positive contribution to the world.
PerkinElmer evaluates and manages product and business risks on a case-by-case basis, incorporating environmental, health and safety considerations into product design and development.
RoHS: As a manufacturer and supplier of electrical and electronic equipment, PerkinElmer produces products that are subject to regulations such as the European Union's directives on the prohibition of the use of certain hazardous substances in electrical and electronic equipment (ROHS) and on the waste of electrical and electronic equipment (WEEE) PerkinElmer closely monitors these and other regulations for the latest developments. PerkinElmer will closely monitor the latest developments in these and other regulations to ensure that our products remain compliant with applicable regulations. PerkinElmer believes it is the company's responsibility to go beyond the corporate realm to effect positive change in local communities and around the world. PerkinElmer strives to be a positive global citizen by listening, engaging in social activities and being a good corporate neighbor.
The company's Employee Activities Committee actively organizes and supports volunteerism, community service and blood drives. Each year, PerkinElmer employee volunteers participate in activities conducted by community service organizations, such as donating food and clothing, rescuing out-of-school children, teaching or tutoring at local schools, rebuilding homes, and walking to raise money.
PerkinElmer Foundation: Founded in 1979, the PerkinElmer Foundation supports U.S.-based charitable organizations in communities where PerkinElmer does business, promoting the company's commitment to human and environmental health. The Foundation is passionate about helping nonprofit organizations dedicated to the early detection and accurate diagnosis of disease and the improvement and protection of the human habitat.
In addition, company officers are required to make annual donations to qualifying nonprofit organizations up to the amount specified by the foundation. PerkinElmer has aligned its product expertise in four key areas:
Diagnostics: Demand for predictive diagnostics, non-invasive diagnostics from consumers and the healthcare community continues to grow due to increasing consumer understanding of the benefits of early disease detection.PerkinElmer is a global leader in two of the fastest-growing industry sectors: Genetic Screening (including prenatal screening and newborn/maternal health screening) and Digital X-ray Imaging, a rapidly growing segment of the $15 billion diagnostics market.
Detection and Analysis: PerkinElmer is a globally recognized innovator of high-performance systems and tools, including precision instruments, chemistries and software, that enable researchers and technicians to detect and analyze samples across a wide range of critical health science and industrial science applications. Within this field, our focus is on biopharmaceutical research and environmental monitoring.
Services: Health sciences companies around the world are more carefully accounting for laboratory maintenance costs in order to find ways to achieve greater organizational and operational efficiencies. These companies are increasingly turning to outsourced maintenance providers to help them achieve their efficiency and profitability goals, and PerkinElmer has leveraged its world-renowned reputation for strong product service and support to develop comprehensive asset management and multi-vendor solutions for companies seeking to enhance their laboratory maintenance and responsibilities.
Optoelectronics: The specialized lighting devices and sensors that make up PerkinElmer's Optoelectronics business are used in a wide range of applications - from medical lighting devices to motion detectors to flash modules for use in next-generation digital still and cellular phone cameras. PerkinElmer is able to combine a customized, collaborative approach to each component it designs with the ability to provide the best of both worlds. customers to realize these expectations by combining a tailored, collaborative approach for each component designed with the scale and efficiencies that customers expect from their global suppliers and distributors.